A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising Biomarkers
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262110722 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Verónica Pulito-Cueto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, 39011 Santander, Spain. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Platelet-Derived Growth Factor, Connective Tissue Diseases, Transforming Growth Factor beta1. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim (Spain), Instituto de Investigación Marqués de Valdecilla, Instituto de Salud Carlos III.
Abstract (Originalsprache)
An early and accurate diagnosis of connective tissue diseases-related interstitial lung disease (CTD-ILD) is crucial for delaying lung fibrosis, but its unknown etiology and the limitations of clinical tools make it challenging for clinicians. PDGF and TGFB are the main profibrotic genes. We evaluated PDGFA, TGFB1, TGFB2, and TGFB3 role in the diagnosis of ILD associated with rheumatoid arthritis (RA), systemic sclerosis (SSc), and inflammatory myopathies (IM). Blood was collected from 289 patients:33 RA-ILD, 31 SSc-ILD, 29 IM-ILD; and 22 RA-nonILD, 18 SSc-nonILD, 8 IM-nonILD; and 148 idiopathic pulmonary fibrosis (IPF). The relative expression was quantified by qPCR. Lower PDGFA, TGFB1, and TGFB2 expression differentiated RA-ILD from RA-nonILD patients, acting as ILD early diagnostic biomarkers in RA with cut-offs of
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, 39011 Santander, Spain.
- Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
- Department of Pneumology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
ORCID-Profile: Verónica Pulito-Cueto, Belén Atienza-Mateo, Joao C Batista-Liz, David Iturbe-Fernández, Víctor M Mora-Cuesta, Ana Serrano-Combarro, Ricardo Blanco
Förderung
- Boehringer Ingelheim (Spain)
- Instituto de Investigación Marqués de Valdecilla
- Instituto de Salud Carlos III
- IDIVAL
- European Social Fund
- ESF
Zitieren
APA
Pulito-Cueto, V., Atienza-Mateo, B., Batista-Liz, J. C., Nieto-Nieto, R., Vaquera-Illescas, C., Sebastián Mora-Gil, M., Iturbe-Fernández, D., Mora-Cuesta, V. M., Serrano-Combarro, A., Izquierdo-Cuervo, S., Aguirre Portilla, C., Cifrián, J. M., Blanco, R., & López-Mejías, R. (2025). A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising Biomarkers. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110722
Vancouver
Pulito-Cueto V, Atienza-Mateo B, Batista-Liz JC, Nieto-Nieto R, Vaquera-Illescas C, Sebastián Mora-Gil M, et al. A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising Biomarkers. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110722
BibTeX
@article{PulitoCueto2025,
author = {Pulito-Cueto, Verónica and Atienza-Mateo, Belén and Batista-Liz, Joao C and Nieto-Nieto, Rebeca and Vaquera-Illescas, Clara and Sebastián Mora-Gil, María and Iturbe-Fernández, David and Mora-Cuesta, Víctor M and Serrano-Combarro, Ana and Izquierdo-Cuervo, Sheila and Aguirre Portilla, Carolina and Cifrián, José M and Blanco, Ricardo and López-Mejías, Raquel},
title = {A New Approach for Achieving Earlier and More Accurate Diagnosis of Connective Tissue Disease-Related Interstitial Lung Disease: TGFB and PDGFA as Novel Promising Biomarkers},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262110722}
}
EUVIMED